SMA
LLY icon

Seven Mile Advisory’s Eli Lilly LLY Stock Holding History

Seven Mile Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Sell
1,085
-180
-14% -$184K 0.87% 22
2026
Q1 		$1.16M Sell
1,265
-541
-30% -$548K 0.84% 20
2025
Q4 		$1.94M Sell
1,806
-13
-0.7% -$12.4K 0.33% 48
2025
Q3 		$1.39M Buy
1,819
+416
+30% +$310K 0.22% 66
2025
Q2 		$1.09M Sell
1,403
-149
-10% -$116K 0.66% 29
2025
Q1 		$1.28M Buy
1,552
+202
+15% +$168K 0.86% 22
2024
Q4 		$1.04M Buy
1,350
+51
+4% +$42.2K 0.66% 27
2024
Q3 		$1.15M Buy
1,299
+163
+14% +$147K 0.76% 24
2024
Q2 		$1.03M Buy
1,136
+44
+4% +$35.2K 0.76% 22
2024
Q1 		$850K Buy
1,092
+32
+3% +$22.8K 0.64% 28
2023
Q4 		$618K Buy
1,060
+57
+6% +$33.3K 0.54% 39
2023
Q3 		$539K Buy
1,003
+34
+4% +$17.5K 0.57% 37
2023
Q2 		$454K Buy
+969
New +$406K 0.53% 44

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Seven Mile Advisory's LLY Position: Q2 2026 in Review

Seven Mile Advisory reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $184K and leaving 1,085 shares worth $1.3M. The position accounts for 0.87% of the portfolio, ranked #22.

Seven Mile Advisory first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.94M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Seven Mile Advisory held 1,085 shares of Eli Lilly worth $1.3M as of Q2 2026.
  • Seven Mile Advisory sold 180 Eli Lilly shares in Q2 2026, an estimated $184K.
  • Eli Lilly made up 0.87% of Seven Mile Advisory's portfolio in Q2 2026, its #22 holding.
  • Seven Mile Advisory first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Seven Mile Advisory's Eli Lilly position peaked at $1.94M in Q4 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.